T cell receptor-induced activation and apoptosis in cycling human T cells occur throughout the cell cycle

Molecular Biology of the Cell

Volumn 10, Issue 12, 1999, Pages 4441-4450

  Karas, Michael ^a   Zaks, Tal Z ^b   Liu, J L ^a   LeRoith, Derek ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; FAS LIGAND; MESSENGER RNA; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL CYCLE PHASE; CELL SYNCHRONIZATION; CONTROLLED STUDY; CYTOLYSIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE CLONE; MELANOMA; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALIA;

EID: 0032736749     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.10.12.4441     Document Type: Article

References (59)

1. Algeciras-Schimnich, A., Griffith, T.S., Lynch, D.H., and Paya, C.V. (1999). Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J. Immunol. 162, 5205-5211.
2. Altman, J.D., Moss, P.A.H., Goulder, P.J.R., Barouch, D.H., McHeyzer-Williams, M.G., Bell, J.I., McMichael, A.J., and Davis, M.M. (1996). Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94-96.
3. Ashwell, J.D., Cunningham, R.E., Noguchi, P.D., and Hernandez, D. (1987). Cell growth cycle block of T cell hybridomas upon activation with antigen. J. Exp. Med. 165, 173-194.
4. Bates, S., and Vousden, K.H. (1996). p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 6, 12-18.
5. Beletskaya, I.V., Nikonova, L.V., and Beletsky, I.P. (1997). Cell cycle specificity of Fas-mediated apoptosis in WIL-2 cells. FEBS Lett. 412, 91-93.
6. Boehme, S.A., and Lenardo, M.J. (1993). Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur. J. Immunol. 23, 1552-1560.
7. Boehme, S.A., and Lenardo, M.J. (1996). TCR-mediated death of mature T lymphocytes occurs in the absence of p53. J. Immunol. 156, 4075-4078.
8. Boise, L.H., and Thompson, C.B. (1996). Hierarchical control of lymphocyte survival. Science 274, 67-68.
9. Brunner, T., et al. (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441-444.
10. Bumbasirevic, V., Skaro-Milic, A., Mircic, A., and Djuricic, B. (1995). Apoptosis induced by microtubule disrupting drugs in normal murine thymocytes in vitro. Scanning Microsc. 9, 509-518.
11. Cohen, P.L., and Eisenberg, R.A. (1991). Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9, 243-269.
12. Cotter, T.G., Glynn, J.M., Echeverri, F., and Green, D.R. (1992). The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res. 12, 773-779.
13. Dao, T., Huleatt, J.W., Hingorani, R., and Crispe, I.N. (1997). Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle. J. Immunol. 159, 4261-4267.
14. Dhein, J., Walczak, H., Baumler, C., Debatin, K.M., and Krammer, P.M. (1995). Autocrine T-cell suicide mediated by APO-1/(Fas/ CD95). Nature 373, 438-441.
15. Donaldson, K.L., McShea, A., and Wahl, A.F. (1997). Separation by counterflow centrifugal elutriation and analysis of T-and B-lymphocytic cell lines in progressive stages of cell division cycle. J. Immunol. Methods 203, 25-33.
16. Drappa, J., Vaishnaw, A.K., Sullivan, K.E., Chu, J.L., and Elkon, K.B. (1996). Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N. Engl. J. Med. 335, 1643-1649.
17. + T lymphocyte clones. J. Immunol. 158, 5612-5618.
18. 2+ signaling modulates cytolytic T lymphocyte effector functions. J. Exp. Med. 187, 1057-1067.
19. Fotedar, R., Flatt, J., Gupta, S., Margolis, R.L., Fitzgerald, P., Messier, H., and Fotedar, A. (1995). Activation-induced T-cell death is cell cycle dependent and regulated by cyclin B. Mol. Cell. Biol. 15, 932-942.
20. Fournel, S., Genestier, L., Robinet, E., Flacher, M., and Revillard, J.P. (1996). Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis. J. Immunol. 157, 4309-4315.
21. Gett, A.V., and Hodgkin, P.D. (1998). Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation. Proc. Natl. Acad. Sci. USA 95, 9488-9493.
22. Graves, J.D., Draves, K.E., Craxton, A., Krebs, E.G., and Clark, E.A. (1998). A comparison of signaling requirements for apoptosis of human B lymphocytes induced by the B cell receptor and CD95/ Fas. J. Immunol. 161, 168-174.
23. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
24. Hodgkin, P.D., Lee, J.H., and Lyons, A.B. (1996). B cell differentiation and isotype switching is related to division cycle number. J. Exp. Med. 184, 277-281.
25. Jha, A.N., Hande, P.M., Mullenders, L.H., and Natarajan, A.T. (1995). Mimosine is a potent clastogen in primary and transformed hamster fibroblasts but not in primary or transformed human lymphocytes. Mutagenesis 10, 385-391.
26. Ji, C., Marnett, L.J., and Pietenpol, J.A. (1997). Cell cycle reentry following chemically-induced cell cycle synchronization leads to elevated p53 and p21 protein levels. Oncogene 15, 2749-2753.
27. Jones, L.A., Chin, L.T., Longo, D.L., and Kruisbeek, A.M. (1990). Peripheral clonal elimination of functional T cells. Science 250, 1726-1729.
28. Ju, S.T., Panka, D.J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D.H., Stanger, B.Z., and Marshak-Rothstein, A. (1995). Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373, 444-448.
29. Kabelitz, D., Pohl, T., and Pechhold, K. (1993). Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 14, 338-339.
30. Klas, C., Debatin, K.M., Jonker, R.R., and Krammer, P.H. (1993). Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5, 625-630.
31. Komada, Y., and Sakurai, M. (1997). Fas receptor (CD95)-mediated apoptosis in leukemic cells. Leuk. Lymphoma 25, 9-21.
32. Komada, Y., Zhou, Y.W., Zhang, X.L., Xue, H.L., Sakai, H., Tanaka, S., Sakatoku, H., and Sakurai, M. (1995). Fas receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle. Blood 86, 3848-3860.
33. Kuwakado, K., Kubota, M., Hirota, H., Adachi, S., Matsubara, K., Kasai, Y., Akiyama, Y., and Mikawa, H. (1993). Aphidicolin potentiates apoptosis induced by arabinosyl nucleosides in human myeloid leukemia cell lines. Biochem. Pharmacol. 46, 1909-1916.
34. Le Deist, F., Emile, J.F., Rieux-Laucat, F., Benkerrou, M., Roberts, I., Brousse, N., and Fischer, A. (1996). Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet 348, 719-723.
35. Lenardo, M.J. (1991). Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353, 858-861.
36. Lissy, N.A., Van Dyk, L.F., Becker-Hapak, M., Vocero-Akbani, A., Mendler, J.H., and Dowdy, S.F. (1998). TCR antigen-induced cell death occurs from a late G1 phase cell cycle check point. Immunity 8, 57-65.
37. MacDonald, H.R. (1978). Restimulation of cytolytic T-lymphocytes in long-term mixed leukocyte cultures. 1. Physical and proliferative characteristics of cytolytic T-lymphocytes restimulated at low cell density. Cell. Immunol. 35, 414-426.
38. Merrill, G.F. (1998). Cell synchronization. Methods Cell Biol. 57, 229-249.
39. Premack, B.A., and Gardner, P. (1992). Signal transduction by T-cell receptors: mobilization of Ca and regulation of Ca-dependent effector molecules. Am. J. Physiol. 263, C1119-C1140.
40. Radvanyi, L.G., Shi, Y., Mills, G.B., and Miller, R.G. (1996). Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis. Cell. Immunol. 170, 260-273.
41. Rensing-Ehl, A., Frei, K., Flury, R., Matiba, B., Mariani, S.M., Weller, M., Aebischer, P., Krammer, P.H., and Fontana, A. (1995). Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur. J. Immunol. 25, 2253-2258.
42. Riddell, S.R., and Greenberg, P.D. (1990). The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J. Immunol. Methods 128, 189-201.
43. Rocha, B., and von Boehmer, H. (1991). Peripheral selection of the T cell repertoire. Science 251, 1225-1228.
44. Rosenberg, S.A., et al. (1988) Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N. Engl. J. Med. 329, 1676-1680.
45. Rouvier, E., Luciani, M.F., and Golstein, P. (1993). Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J. Exp. Med. 177, 195-200.
46. 2+ from inositol trisphosphate-and phosphatidic acid-sensitive intra-cellular stores through a mechanism independent of inositol trisphosphate. J. Biol. Chem. 271, 11148-11155.
47. Sarin, A., Williams, M.S., Alexander-Miller, M.A., Berzofsky, J.A., Zacharchuk, C.M., and Henkart, P.A. (1997). Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity 6, 209-215.
48. Sekaly, R.P., MacDonald, H.R., Zaech, P., Glasebrook, A.L., and Cerottini, J.C. (1981). Cytolytic T lymphocyte function is independent of growth phase and position in the mitotic cycle. J. Exp. Med. 154, 575-580.
49. Tanaka, M., Suda, T., Takahashi, T., and Nagata, S. (1995). Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J. 14, 1129-1135.
50. Topalian, S.L., Muul, L.M., Solomon, D., and Rosenberg, S.A. (1987). Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J. Immunol. Methods 102, 127-141.
51. Tourigny, M.R., Mazel, S., Burtrum, D.B., and Petrie, H.T. (1997). T cell receptor (TCR)-beta gene recombination: dissociation from cell cycle regulation and developmental progression during T cell ontogeny. J. Exp. Med. 185, 1549-1556.
52. van Engeland, M., Nieland, L.J., Ramaekers, F.C., Schutte, B., and Reutelingsperger, C.P. (1998). Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31, 1-9.
53. Van Parijs, L., Ibraghimov, A., and Abbas, A.K. (1996). The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4, 321-328.
54. Walter, E.A., Greenberg, P.D., Gilbert, M.J., Finch, R.J., Watanabe, K.S., Thomas, E.D., and Riddell, S.R. (1995). Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038-1044.
55. Weis, M., Schlegel, J., Kass, G.E., Holmstrom, T.H., Peters, I., Eriksson, J., Orrenius, S., and Chow, S.C. (1995). Cellular events in Fas/APO-1-mediated apoptosis in Jurkat T lymphocytes. Exp. Cell Res. 219, 699-708.
56. Zaks, T.Z., Chappell, D.B., Rosenberg, S.A., and Restifo, N.P. (1999). Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition. J. Immunol. 162, 3273-3279.
57. Zaks, T.Z., and Rosenberg, S.A. (1998). Immunization with a peptide epitope (p369-377) from HER-2/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2/neu+ tumors. Cancer Res. 58, 4902-4908.
58. Zheng, L., Fisher, G., Miller, R.E., Peschon, J., Lynch, D.H., and Lenardo, M.J. (1995). Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377, 348-351.
59. Zhu, L., and Anasetti, C. (1995). Cell cycle control of apoptosis in human leukemic T cells. J. Immunol. 154, 192-200.